Print   

Thursday 26 June, 2008

NeutraHealth Plc

Annual Report and Accounts

RNS Number : 5891X
NeutraHealth Plc
26 June 2008
 




NEUTRAHEALTH PLC ('the Company')


The Company announces that is has posted its annual report and account to shareholders and that these may also be viewed on the Company's website: www.neutrahealthplc.com'


For more information:

Further information for investors is available on the Company's website at www.neutrahealthplc.com/


NeutraHealth plc


Michael Toxvaerd, Deputy Chairman

07730 581 584

Robin Hilton, Finance Director    

07738 018 411



Cenkos (Nominated Adviser and Broker)


Stephen Keys

020 7397 8900





Notes:

NeutraHealth was floated on AIM in February 2005 with the strategy of consolidating the fragmented Vitamins, Minerals and Supplements sector of the growing nutraceutical market. The company is focused on building a group of companies within the nutraceutical market which will deliver growth through organic expansion and through strategic acquisitions.


The company made its first acquisition, BioCare, in August 2005 for £16.1m, and has made three subsequent acquisitionsRecent events include:




January 2007

  • Acquisition for £4.0m of Brunel Healthcare Limited, an established supplier of nutraceutical products and over the counter medicines sold by major retailers across the UK.


April 2007

  • Signed three year agreement with the UK's leading high street retailer of vitamins, minerals and supplements to continue to supply products under private label until at least August 2010, contractually underpinning 20% of current group sales


July 2007

  • Acquisition of Health Products for Life for £0.4m, a direct to consumer website 

  • Signing of licensing agreement with leading nutrition expert Patrick Holford


August 2007

  • Net £5.3 million investment in 20% of NeutraHealth by Elder Pharmaceuticals Limited of India through issue of shares at 16p

  • Investment made at a 36% premium to mid-market price on day of announcement

  • Funds raised for future acquisitions, and opportunities for distribution and manufacturing between businesses


January 2008

  • Acquisition of Galloways and Gerard House brands and herbal licenses for £0.4m




This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSFKAKKCBKKDAB

Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.